Effect of heparin, aggregation inhibitors and vasoactive substances on chronic-obliterative vascular diseases
Wenzel, E.; Nienhaus, K.H.; Bahre, G.; Holzhüter, H.; Angelkort, B.; Meyer-Erkelenz
Die Medizinische Welt 27(25): 1242-1247
1976
ISSN/ISBN: 0025-8512 PMID: 933811 Document Number: 104158
Document emailed within 1 workday
Related Documents
Kitamura, S.; Ishihara, Y.; Sasaki, K. 1977: Effect of vasoactive substances on the cyclic nucleotide contents of guinea-pig lung and tracheal tissues. 2. Effect of different doses of vasoactive substances Nihon Kyobu Shikkan Gakkai Zasshi 15(7): 391-398Janssens, W.J.; Cools, F.J.; Hoskens, L.A.; Van Nueten, J.M. 1990: Effect of ridogrel on vascular contractions caused by vasoactive substances released during platelet activation Thrombosis and Haemostasis 64(1): 91-96
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Kitamura, S.; Ishihara, Y.; Hsu, L.H.; Sugiyama, Y. 1979: Effects of vasoactive substances on the canine airways and on pulmonary vascular bed Nihon Kyobu Shikkan Gakkai Zasshi 17(9): 567-573
Fukushima, S.; Ohashi, T. 1989: Effects of vasoactive substances on vascular smooth muscle of various body parts in monkeys Nihon Heikatsukin Gakkai Zasshi 25(6): 297-299
Lüscher, T.F.; Yang, Z.H.; Diederich, D.; Bühler, F.R. 1989: Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion Journal of Cardiovascular Pharmacology 14(Suppl 6): S63-S69
Kitamura, S. 1985: Roles of vasoactive substances in various pulmonary diseases Nihon Kyobu Shikkan Gakkai Zasshi 23(12): 1411-1415
Kirillov, I.B. 1973: Amputations in obliterative vascular diseases of the lower limbs Klinicheskaia Khirurgiia 6: 67-73
Ordyński, J. 1972: Effect of various therapeutic methods on the basophil count in peripheral blood and sensitivity to heparin and heparin-like substances in rheumatic fever in children Pediatria Polska 47(9): 1089-1096
Davydova, L.I. 1978: Study of central and peripheral hemodynamics in obliterative vascular diseases of the extremities Klinicheskaia Khirurgiia 7: 50-52
Kudriavtsev, B.P.; Charushin, M.V.; Logush, N.O.; Paĭvin, A.A.; Fomenko, V.P. 1996: Lumbar sympathectomy in the combined treatment of obliterative vascular diseases of the lower extremities Voenno-Meditsinskii Zhurnal 317(12): 18-20
Neagu, M.; Manda, G.; Constantin, C.; Tanaseanu, C.; Mikhailidis, D.P. 2001: The in vitro effect of a low molecular weight heparin, nadroparin (Fraxiparine), on leukocytes obtained from patients with vascular diseases International Angiology: a Journal of the International Union of Angiology 20(2): 164-173
Panchenko, K.I. 1979: Effect of vasoactive substances on the morphogenesis of allergic contact dermatitis Vestnik Dermatologii i Venerologii 4: 14-18
Tsuiki, K. 1988: Selective augmenting effect of oxy-Hb on the contractions of cerebral arteries elicited by various vasoactive substances No Shinkei Geka. Neurological Surgery 16(10): 1155-1162
Petronio, G.; Scali, G.; Casa, B.; Nonis, E. 1980: Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients La Clinica Terapeutica 94(4): 427-444
Jones, R.; Kirton, O.C.; Zapol, W.M.; Reid, L. 1986: Rat pulmonary artery wall injury by chronic intermittent infusions of Escherichia coli endotoxin. Obliterative vasculitis and vascular occlusion Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 282-294
Loew, D.; Hess, H. 1982: Aggregation inhibitors or anticoagulants in the prevention of peripheral arterial occlusive diseases Die Medizinische Welt 33(43): 1511-1515
Davies, J.A.; Menys, V.C. 1982: Effect of heparin on platelet monolayer adhesion, aggregation and production of malondialdehyde Thrombosis Research 26(1): 31-41
Bicher, H.I. 1970: Anti-thrombotic effect of an heparin-like substance (SP 54) preventing red cell and platelet aggregation Arzneimittel-Forschung 20(3): 379-381
Chong, B.H.; Pitney, W.R.; Castaldi, P.A. 1982: Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation Lancet 2(8310): 1246-1249